HALO  valuation analysis

Name: Halozyme Therapeutics Inc
Description: Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 10, 2022
Market cap: $6.54B (594th)
Sales(TTM): $471.57M (1257th)
Earnings(TTM): $434.92M (563rd)

FFER: 2.24 (why)
Actual price: $46.29
FFEThis is Halozyme Therapeutics Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $20.67
Quantile: HALO is very expensive given its fundamentals.
Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
No notables found through heuristics.
Earnings / MarketCap
Halozyme Therapeutics Inc
"Biotechnology" industry
Sales / MarketCap
Halozyme Therapeutics Inc
"Biotechnology" industry
Book / MarketCap
Halozyme Therapeutics Inc
"Biotechnology" industry
Equity / Assets
Halozyme Therapeutics Inc
"Biotechnology" industry